Motor Neurone Disease Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
Autologous Multipotent Mesenchymal Stromal Cells in the Treatment of Amyotrophic Lateral Sclerosis
Condition: Motor Neuron Disease, Amyotrophic Lateral Sclerosis Intervention: Biological: Suspension of human autologous MSC 3P in 1.5 ml Sponsors: Bioinova, s.r.o.; Department of Neurology, University Hospital Motol, Prague, Czech Republic Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 4, 2019 Category: Research Source Type: clinical trials